The expansion, which was completed last year, added a whole floor dedicated to emergency and critical care, a new specialist oncology treatment area and additional theatre space.
Davinia Arnott (pictured right), a European and RCVS Specialist in Small Animal Surgery, is leading the new residency programme. She said: "To be awarded the ability to run a residency, you have to be accredited to the highest possible standard, and there is a range of stringent ECVS criteria that we needed to meet.
"We were able to put ourselves forward following the expansion of our hospital and all the new facilities we have added. We are all really proud to be in a position to offer this new small animal surgical residency.
"We now have four theatres so we can do multiple surgeries at the same time, allowing us to greatly increase our caseload. We can also do fluoroscopy for orthopaedics and soft tissue. We just didn’t have that capability before.
"To achieve specialist status, the standard is exceptionally high so we’ll only have one resident every three years. This is to ensure they’re mentored and guided properly throughout."
Leo Roses is the first small animal surgery resident to join the new Vets Now programme. She began her three-year tenure in January after completing a surgical internship in the hospital. Leo, who is originally from Majorca and has also worked for Vets4Pets, Fitzpatrick and PDSA, is realising a long-held dream by embarking on a surgery residency.
She said: "I realised during my degree that I wanted to specialise in surgery. I did two surgical internships before coming to Glasgow to do a third. I applied for a position here because I was aware of the incredible reputation of the surgeons and had been told they were really keen to teach."
First prize went to the University of Edinburgh’s Molly Vasanthakumar (pictured right) for her Knowledge Summary comparing the ecological impact of woven versus disposable drapes. Molly found that there is not enough evidence that disposable synthetics reduce the risk of surgical site infections when compared to reusable woven drapes, based on her assessment of the available literature.
Molly said: “The Veterinary Evidence student competition gave me an opportunity to identify a specific issue, find and appraise the evidence and then apply it to a practical setting.
"Winning the competition has given me a chance to further my skills in evidence-based veterinary medicine [EBVM] and also raise awareness of an incredibly important and topical issue."
Molly received her prize at RCVS Day, and her published paper can now be read in Veterinary Evidence: http://bit.ly/MollyVasanthakumar
Second prize went to Honoria Brown of the University of Cambridge, whose paper asked: "Can hoof wall temperature and digital pulse pressure be used as sensitive non-invasive diagnostic indicators of acute laminitis onset?"
Honoria said: "Writing this Knowledge Summary was the perfect chance, not only to develop my ability to navigate and analyse databases, but also to present my findings for the benefit of other clinicians who face these issues.
"I feel that these skills will be very useful to me later in my career, and I am grateful to Veterinary Evidence for providing me with the opportunity."
Jacqueline Oi Ping Tong from the University of Edinburgh won third prize for her critical appraisal of the evidence for whether a daily probiotic improved clinical outcomes in dogs with idiopathic diarrhoea. She said: "This experience makes me recognise the importance of evidence-based veterinary medicine to the veterinary community; it connects scientific research to everyday practice.
"It was a great opportunity to engage in EBVM early in my veterinary career, and start learning how to critically appraise the current evidence."
Jacqueline and Honoria’s Knowledge Summaries have been accepted for future publication in Veterinary Evidence.
All submissions were subjected to the same standards and peer-review process as normal journal submissions.
RCVS Knowledge’s Executive Director, Chris Gush, said: "EBVM and its application into practice starts as part of the undergraduate degree, and we are delighted to encourage and champion student involvement.
"This new initiative from our journal taps into the student body’s potential to help grow the evidence base, whilst preparing the next generation of veterinary professionals for when they graduate."
The Veterinary Evidence Student Awards are running again for 2020 and are open for submissions.
The awards are open to all undergraduates studying veterinary medicine, veterinary nursing or bioveterinary science (and equivalent). More information can be found here: http://bit.ly/VEstudentawards
Virbac Animal Health has launched CaniLeish, the first vaccine for canine leishmaniosis in the European Union.
Leishmaniosis is a vector-borne parasitic disease caused by infection with protozoa of the genus Leishmania (L infantum in Europe). Leishmaniosis is transmitted by the bite of infected sandflies. In south-western Europe 2.5 million dogs are believed to be infected1,2 with the parasite and the disease is spreading northwards,3 as more people travel with their dogs or import infected animals from endemic areas.4 So far preventative methods have been limited to reducing the habitat of sandflies, minimising the physical contact of dogs with sandflies and using insecticides on dogs (sprays, spot-ons, repellent-collars, etc).
According to Virbac, CaniLeish's ability to protect dogs was demonstrated in an experimental challenge study, where the benefit of vaccination was still evident after one year.5 In an extreme condition natural challenge trial lasting two years under environmental conditions rarely encountered in reality, 93% of dogs vaccinated with CaniLeish did not develop symptomatic leishmaniosis. CaniLeish provides a fourfold reduction in the risk of developing this fatal disease. 6 Its safety profile has been shown in laboratory testing and field trials.7 In addition, Virbac says it contains no whole parasites that could be virulent in any host.
David McGahie BVMS Bsc (VetSci) MRCVS, Medical Department Manager at Virbac SA, said: "The development of this vaccine is a key milestone in the battle against this challenging disease which is a major problem in many regions of the world. Although in the past it was considered a rather exotic disease here in the UK, the advent of the Pet Travel Scheme means it has become increasingly important as a problem for dogs which regularly travel abroad to endemic regions."
CaniLeish can be given to dogs as young as six months of age: the primary course consists of three injections given over six weeks. Dogs should be re-vaccinated annually, with a single dose administered one year after the third injection and annually thereafter.
References:
Andrew, who is head of dentistry and oral and maxillofacial surgery at Eastcott Referrals in Swindon simultaneously became an RVCS Specialist in Veterinary Dentistry.
Eastcott Referrals managing director Peter Southerden, who is also a recognised EVDC specialist in dentistry, said: "This is a terrific achievement by Andrew.
"He’s spent six years studying on the EVDC’s training programme which finally culminated in four days of intense examinations.
"He now joins just eight other veterinary dentists in the UK who are recognised by the EVDC."
Andrew is now planning to build on his qualifications. He said: "I aim to start studying again in January when I hope to begin a Fellowship of the American College of Veterinary Surgeons in oral and maxillofacial surgery.
"The Fellowship is overseen by the American College of Veterinary Surgeons (ACVS) and is a post-specialist qualification indicating further specialisation in maxillofacial surgery.
"It’s two more years of study, including the need for publication in an international journal, and then an exam in the US.
"The primary benefit is the continued development of my skills, insuring that, here at Eastcott, we are operating to the highest international standards and can treat patients with the most complex problems.
"Peter is an ACVS Founding Fellow in Oral and Maxillofacial Surgery, currently the only fellow of the ACVS in Europe, so I’m proudly following in his footsteps to become the first resident of the Fellowship in Europe.
"It shows our commitment to dental and maxillofacial work and we believe we are leading the way with our cutting-edge surgical procedures and innovations within our state-of the-art facilities.
"We are not just one of the foremost centres of excellence for this specialist work in the UK but throughout Europe, too."
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a Schedule Two Controlled Drug, without having to complete the online training programme which was has been mandatory since the launch of the product in April 2013.
The company says that training is still highly recommended for every veterinary professional that handles Recuvyra due to its new delivery system. This can be via the short online training course available at www.recuvyratraining.eu or by reading the training leaflet provided with every vial of Recuvyra. The training leaflet includes information on instructions for use, correct administration of the product and special precautions. In addition, client leaflets and other support materials will continue to be available to vets via the website.
Alice Laurens, Recuvyra product manager at Elanco Companion Animal Health, said: "Veterinary practices will still need to follow their wholesalers' procedures for ordering Schedule Two Controlled Drugs when purchasing Recuvyra, however any vet from the practice can now order and sign for delivery of the product making it easier to purchase."
For further information about Recuvyra or Elanco's surgery and pain management range, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
According to the blurb, A Practical Approach to Diagnosis and Management of Cardiac Arrhythmias will support delegates in developing an analytical approach to electrocardiogram (ECG) trace interpretation and help them to identify bradycardias, narrow and wide complex tachycardias and to select appropriate management options. The course takes place on Thursday 20th September 2018.
Cardiac Emergencies in Small Animal Practice will equip delegates to select the latest techniques to diagnose and manage commonly presented cardiac emergencies. They will learn the theory and practical application of point-of-care ultrasonographic techniques for diagnosis of pleural effusion, pulmonary oedema, pericardial effusion and ascites. They will also develop Centesis techniques and improve their knowledge of Acute Heart Failure. The course takes place on Friday 21 September 2018.
Juliet Pope from Improve said: "Emergency cardiac care is an area of growing importance to first opinion practitioners. These two courses have been carefully designed to provide a comprehensive overview of the latest techniques and management approaches which delegates will be able to utilise immediately in practice."
For more information contact Improve on 01793 759159.
The Easy to Give Awards are given to pharmaceutical companies that have made it easier to give medication to cats:
Dechra for Felimazole coated tablets for cats
Zoetis for Stronghold Plus spot-on solution for cats
Zoetis for VibraVet Paste
Bayer for Seresto flea and tick collar for cats
The Cat Friendly Awards recognise products which have made a difference to cat wellbeing:
ProtectaPet for cat fencing solutions
Coastline Global for Kit4Cat Cat Urine Sample Collection Sand
Sure Petcare for its SureFlap Microchip Pet Door Connect with Hub
The Distance Education Awards recognise the best students on the International Society of Feline Medicine’s Vet Nursing courses
Sarah Hayward and Rachael Hodgeson for best results achieved in the Certificate in Feline Nursing
Margaret Hodgeson for the best result received in the Diploma in Feline Nursing
In addition, International Cat Care made a special award in 2018 for products and ideas which have made major contributions to the ability to help cats in the field of Trap, Neuter, Return (TNR). The Innovation in Humane Cat Population Management Award was given to MDC Exports for its traps, restrainers and transfer baskets.
Lastly, the winner of the 2018 iCatCare Photography Competition winner, awarded to the overall winner of the charity’s ‘Kittenhood’ photo competition, was Lindsey Chadwick.
Photo: Liz Rawlings and Craig Sankey from Dechra with their Easy to Give award for Felimazole
Hertfordshire-based, multi-specialist veterinary referral centre Davies Veterinary Specialists' new pro bono scheme has saved the life of a young German shepherd dog twice in fortnight.
'Apollo' first impaled himself on some broken fence panels whilst playing. A splinter of wood, which was around 5cm long and 1.5cm wide, became lodged between his heart and lungs. However, because he initially had no symptoms and there was no obvious puncture wound, his owner Sam Russell from Leighton Buzzard wasn't aware that anything was wrong. It was a week later when the dog suddenly became very anxious, uncomfortable and was struggling to breathe, that Sam rushed him to her local vet practice, Heath and Reach in Bedfordshire.
Hannah Johnston's initial diagnosis was that the dog had some foreign material lodged internally that was causing an infection. Without an urgent CT scan and surgery his chances of survival were minimal, but his owner was uninsured and had no means of affording the treatment. Hannah had recently read about a pro bono scheme introduced by Davies Veterinary Specialists and believed that Apollo's case fitted the criteria.
She said: "It was heart wrenching to think that a young dog, with such a caring owner, was very likely to lose his life and I was determined to do anything I could to help. I couldn't help shedding a tear when DVS agreed to treat him, as I knew Apollo now had a chance. His owner had recently had an awful spate of bad luck and was so deserving of DVS's help."
Manuel Jiménez Peláez, European Veterinary Specialist in Surgery at DVS, who operated on Apollo, said: "A CT scan showed a large, fluid-filled cavity, a partially collapsed lung and a sharp, thin, elongated structure, lodged between Apollo's lungs and his heart. We drained the cavity and successfully removed the foreign body. We also had to remove most of the irreparably damaged left lung."
Apollo was in hospital for two weeks, five days of which were spent in intensive care in a critical condition. Sam was thrilled when she was eventually able to take him home, but two days later disaster struck again. Apollo was diagnosed with gastric dilation volvulus. He needed surgery within six hours to survive the condition and DVS once again stepped in to operate as an emergency, free of charge.
Apollo has made a full recovery is now back at home with the Russell family. Sam Russell said: "Apollo has always been so determined and full of life. Even when he was dangerously ill and in intensive care he wouldn't give up and tried to rouse himself to come home with me. For Davies Vet Specialists to save my dog once is nothing short of amazing but for them to save him twice makes me speechless with gratitude. To be shown such kindness after a dreadful run of bad luck would leave anyone stuck for words."
All first opinion practices are eligible to apply for the DVS pro bono scheme, which will allow an average of one patient per month to receive free treatment. Requests will be based on advocacy from the clinical head of the referring practice and on genuine need. To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood, Managing Director, on 01582 883950.
Dechra Veterinary Products has announced that Intubeaze Oromucosal Spray is now back in stock.
Intubeaze is used for local anaesthesia of the laryngeal mucosa of cats to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.
The product had gone out of stock due to a temporary manufacturing problem which has now been fixed.
Intubeaze is a clear solution containing 2% w/v lidocaine hydrochloride, with 0.1% w/v chlorocresol as an antimicrobial preservative. Intubeaze is now available through all wholesalers.
For further information on Intubeaze please contact Dechra on 01743 441 632 or visit www.dechra.co.uk.
The survey found that 51% of cat and dog owners didn't research their pets breed before buying. Of the 22% who then regretted their decision, 31% said it was because they didn’t have enough time to look after the animal, 18% because they turned out to be allergic to the animal, and 16% because they didn’t like their pet’s personality.
Apparently dog owners were more likely to regret their new pet (26%) than cat owners (16%).
Sainsbury’s has therefore launched the Pawfect Match tool, designed to help future pet owners to make informed decisions when choosing the most suitable breed for them. The pet picker asks you a number of questions about your circumstances and makes a number of suggestions based on how you answer.
Sainsbury's campaign is being fronted by Scott Miller MRCVS, who said: "I am saddened to hear that so many pet owners are regretting the animals they have chosen as companions. Dogs and cats come in all shapes and sizes, and have different temperaments. Looking after a pet is a huge commitment so it is important that people undertake adequate research before buying a pet to ensure it is a happy experience."
COMMENT
I tried Sainsbury's pet picker and it recommended a Basset Hound as the first choice. Fair enough. I always think they look like the living embodiment of the word 'hangdog', which is not really my cup of tea. Luckily, the tool makes more than one suggestion. One of the criteria I'd specified was 'quiet and calm', so the second recommendation, a whippet, was fine. But the third caught my eye. A Border Collie. What? Whaaaaaat? Quiet and calm? A Border Collie. Are you having a laugh? I thought Border Collies usually need to be sent to some sort of asylum.
Still, if Sainsbury's tool encourages more people to think harder about their choice, that's no bad thing. But they might like to rethink the Border Collie recommendation.
In current regional anaesthesia procedures two operators are often needed, with an assistant using 'feel' to inject the anaesthetic solution at the required pressure. This, says the company, means anaesthetic solutions can be injected at unsafe pressures. The new device incorporates a safety system that limits injection pressure, to reduce the risk of nerve injury.
Dr. Federico Corletto, Consultant Anaesthetist from Dick White Referrals said: “By turning regional anaesthesia into a one-person procedure, the technology also removes the challenges of communicating with an assistant regarding subjective injective pressure feel, thus removing the unpredictability of an untrained hand.”
Medovate says the use of ultrasound guided regional anaesthesia is becoming more common practice today, with the technique – which can help provide a higher level of visualisation for the practitioner – increasingly seen as a ‘gold standard’.
However, there are limitations and challenges that are not always present in the practice of adult human medicine. Nerve parathesia, for instance, is harder to ascertain in animals. Small animals such as cats also have increased sensitivity to local anaesthetics when compared with other species, necessitating much lower maximum doses be used.1
Brett Hughes, Homecare & Veterinary Business Manager at Vygon UK, said: "The device infuses at 0.5ml/second, and to vets the technology offers a valuable tool that can control injection small intervals at a time. This allows the veterinary practitioner to titrate appropriately to see the anaesthesia spread around a nerve bundle.
"There are a significant number of regional anaesthesia blocks completed in veterinary practice per annum globally, so potentially this NHS developed device could play a major role in the future of veterinary practice."
For more information, visit: https://www.medovate.co.uk/veterinary/safira-for-veterinary-applications and https://www.vygonvet.co.uk/
Reference
The new range allows for gradually increasing support for the CKD patient according to the International Renal Interest Society (IRIS) stage, reducing phosphorous levels whilst avoiding early protein reduction and the associated lean mass loss correlated to a reduction in life expectancy.
Virbac says Veterinary HPM Kidney & Joint contains high quality protein, of which more than 85% is of animal origin, to support body condition and limit renal workload.
All of the products in the range contain Mobility Plus Complex, a mix of chondroprotective agents for joint support which are designed to increase joint flexibility and mobility with high levels of Omega 3 and DHA.
Dan Johnson, Product Manager at Virbac said: "CKD is the first cause of mortality at, or after, 5 years of age and osteoarthritis is highly prevalent but under-diagnosed in senior cats, with most cats being diagnosed at an advanced stage.
"So with Veterinary HPM Kidney & Joint, Virbac hopes to provide clinicians with a significant advancement in the nutritional management of these feline pathologies."
Veterinary HPM Kidney & Joint is presented in three dry and two wet formats:
IVC says this means its UK practices are on track to hit a group target of 5% by 2030, which follows in the footsteps of other IVC Evidensia territories such as Sweden and Norway, which have already reached figures of 4.9% and 5.9% respectively.
To achieve this progress, IVC says it has implemented a number of initiatives:
IVC says there has been a concerted efforts by its vets to become more aware of their own attitudes towards antibiotics and to educate their clients about the dangers of AMR.
One such example is Angharad Thomas, a veterinary surgeon from Fivelands Veterinary Centre in the West Midlands, who managed to reduce the amount of antibiotics prescribed in dentistry by 17.8% between 2022 and 2023:
She said: “Long dental treatments are a great time to chat to vet students, but one day, instead of quizzing them, I was trotting out my thoughts on the decision-making for the case when I reached post-operative drugs.
"Stopping here I asked: ‘What are you taught about this these days?’
"I suppose I wasn’t surprised to hear that antibiotics didn’t feature.
“It was a lightbulb moment: Why was I using post-operative antibiotics for my dental cases?
"I come from the generation of vets who were firmly taught never to give antibiotics to routine surgeries, so why was I continuing to use antibiotics in dentistry?
"All at once I felt terribly old and out-of-touch. I decided it was time for a change!”
“Given that reducing antibiotic usage is now fairly well recognised by the general public, owners have appeared very supportive.
"A day three post-operative check provides reassurance that their pet is healing and allows us an opportunity to intervene if required.”
“Being an ‘experienced’ vet can be a trade-off between textbook clinical decision-making and what we believe would work for our patients and their owners.
"Sometimes we need a paper or two to persuade us to change our ways, but here, going back to basic principles was enough for me.
“Twelve months later, after watching my cases for any mild complications and reflecting on the whether such complications could be attributed to the lack of antibiotics, I am convinced that this change has had no negative effects on my patients.”
https://ivcevidensia.co.uk/positive-pawprint
Abbott Animal Health is launching GLUture Topical Tissue Adhesive this month.
Abbott says GLUture is an Octyl/Butyl cyanoacrylate blend that creates a strong and flexible bond that contours to the wound site. GLUture applies purple for visibility and dries clear for a neat cosmetic appearance. Offered in an economical multi-use package with 10 applicators, GLUture's viscosity and applicator design enable flow-controlled application. GLUture topical tissue adhesive offers a flexible seal, quick application and a strong bond.
For more information, ring Abbott on 01628 644354, or visit: www.abbottanimalhealth.com
The strange phenomenon was spotted by Veterinary Vision's clinical director Chris Dixon when he examined Dachshund called Margo, which had been referred for the treatment of a corneal ulcer and fungal infection.
Chris said: “I was assessing Margo’s eye and was very surprised to see a face smiling back at me.
"It perhaps doesn't bear quite the same resemblance as the Turin Shroud. Still, I've never seen anything like it before.
"The good news is that it does not appear to have affected her vision at all.”
Apparently the smiling face is still there, even after Chris performed a corneal graft.
Chris added: "I think we can safely say that Margo is a very happy dog, both inside and out!"
Ceva says this is the first time it has advertised Feliway Friends - designed to help cats live together in harmony - on television. It will be rotating the Feliway advert with one explaining the benefits of the Adaptil Calm On-the-Go Collar.
Both advertisements are 30 seconds long and the campaign runs until the end of June. It will target 24.5 million pet owners and will air on all Channel 4 and Channel 4 partner channels, including Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home.
Abigail King, product manager for Feliway and Adaptil at Ceva, said: "Our summer TV advertising campaign will raise awareness of how Feliway Friends and Adaptil Calm On-the-Go Collar can help pets with behavioural issues and drive customers to veterinary practices for further information and to purchase product."
For further information, visit www.feliway.com or www.adaptil.com.
The Disciplinary Committee heard three charges against Dr Jones.
The first and second charges were that, in March 2018, Dr Jones made signed entries in the passports and made corresponding entries in clinical records of four horses indicating that he had administered an influenza vaccination booster to each horse on 15 March 2018 and in relation to another horse a tetanus booster, when in fact he had administered the vaccination boosters on 21 March 2018, and that his conduct was misleading, dishonest and undermined the integrity of a vaccination process designed to promote animal welfare.
The third charge was that, on or around 21 March 2018, Dr Jones failed to make any entries in the clinical records for a horse in relation to an examination on 21 March 2018.
At the outset of the hearing Dr Jones admitted the facts in the first and second charges, and accepted that his actions were misleading, dishonest and that they undermined the integrity of a vaccination process. However, he disputed certain aspects of the written statements of the College’s witnesses. In particular he wanted his conduct to be taken in the context of the pressures that he was working under on that day, primarily that he was in a stressed state having had to euthanase a valuable stallion at the conclusion of his previous client appointment.
Dr Jones did not admit the third charge, explaining that he did not remember examining the horse on 21 March 2018 as alleged.
Based on Dr Jones' own admissions, the Committee found the first and second charges proven.
Regarding the third charge, the Committee heard evidence from the horse’s owner who said they were present during the examination taking place and the Committee was satisfied that the respondent did examine the horse on 21 March 2018 and that he had a duty to make a brief clinical note on the examination. As Dr Jones admitted that he made no such note, the Committee found the charge to have been proven to the requisite standard.
Having found the charges proven, the Committee then went on to consider whether or not Dr Jones’ proven conduct amounted to serious professional misconduct. The Committee, having considered the aggravating and mitigating factors, found that Dr Jones’ conduct as found proved in relation to both charges one and two, did constitute serious professional misconduct.
However, with regards to charge three, the Committee accepted that the respondent simply forgot that he had examined the horse and, therefore, the Committee was not satisfied that the failure to compile a record entry covering the horse’s examination constituted serious professional misconduct.
The Committee then considered what sanction to impose on Dr Jones in relation to the facts found proven in charges one and two. In doing so it took into account the 78 written testimonials and 4 character witnesses called on behalf of Dr Jones.
Ian Green, who chaired the Committee and spoke on its behalf, said: "The Committee’s decision on sanction has been based on an acceptance that the respondent’s conduct on this occasion was out-of-character, as the evidence of his character witnesses and the contents of the letters submitted in his support by his clients and other veterinary colleagues assert. The Committee also accepts that the respondent self-reported himself to his employer and to the College and has made a full and frank admission of his wrongdoing.
"Consideration was given to whether the sanction of a reprimand and/or warning as to future conduct would adequately reflect the gravity of the misconduct, however, after careful reflection it was concluded that such a sanction could not be justified. The reason is that acts of falsification involve acts of dishonesty by a professional person acting in a professional capacity, and the gravity of the matter arises not simply from the dishonesty but also from the possible consequences of the false certification. It should be clearly understood by members of the veterinary profession that, in appropriate false certification cases, the sanction of removal from the Register is one which may well be imposed."
The Committee therefore decided that suspending Dr Jones from the Register for two months would be the most appropriate sanction.
Kriptazen is supplied with a twist-adjustable and weight-graduated dosing pump which means farmers can administer a precise dose up to 60kg without having to calculate it in ml’s first. Virbac says this will help to reduce the risk of incorrect dosing and toxicity issues.
Virbac’s Technical Product Manager Rosie Naylor said: "We are delighted to bring Kriptazen to the market. The trusted active halofuginone, along with the innovative weight graduated dosing pump, provides practices with added peace of mind when it comes to treatment."
For more information, contact your Virbac Territory Manager.
AniDent is a dental care range for cats and dogs - a rinse, a toothpaste and a gel - created with Virbac to help prevent periodontal disease.
Anident joins VetSoothe, a range of dermatology products which includes shampoos, ear cleaners and skin wipes, developed with Vetruus.
Earlier in the year, IVC also launched Joints & Mobility with Omega-3s, an addition to it's VetPro range, developed with one of the company's orthopaedic experts, Jamie McClement.
On the equine side, the company has also launched EquiXcellence, a range of equine nutritional health and wellbeing supplements.
VetSurgeon asked what longer term plans the company has for its exclusive brand product range.
An IVC Evidensia spokesperson said: "We're developing own brand veterinary products specifically where we think we can see areas we can add value for our practices, pet owners, and patients. In the case of Anident, we saw there was an opportunity to make oral care easier by offering a range of options to suit pet owners' needs.
"In the case of Joints & Mobility with Omega-3s, there is research which has shown that high levels of Omega-3s EPA & DHA can greatly support freedom of movement and pain, which was the key focus when developing the product.
"We plan to continually enhance our own brand portfolio across our UK and Europe practices with some exciting product launches on the horizon."
Photo: Gerhard Putter BVSc MRCVS MANZCVS (Veterinary Dentistry and Oral Surgery) Diplomate of the European Veterinary Dental College uses Anident on a big cat
As part of the new arrangement, Battersea will give StreetVet operational and logistical support, including advice from its staff, clinical support, and kennel space for animals in urgent need of care.
Battersea also plans to work with StreetVet on a range of projects that will help the charity to reach more dogs in need. For example, providing advice and training to hostel staff to promote and facilitate hostels accepting dogs – creating more safe places to sleep for both dogs and their owners.
Battersea’s Deputy Chief Executive, Peter Laurie, said: "I’m excited at the prospect of Battersea and StreetVet coming together for a partnership that aligns both organisations’ strategic values. Both of us care deeply about the welfare of dogs, particularly those most in need. StreetVet relies almost entirely on the support of a growing network of volunteers, including members of the Battersea clinic team, and is a great example of a volunteer-led organisation delivering significant impact on a wide geographical scale. By working together, we can increase our collective impact and help more animals in need."
Sam Joseph MRCVS, a co-founder of StreetVet, said: "We are really excited about the official partnership between StreetVet and Battersea. As a small, growing charity, StreetVet will hugely benefit from the expertise, infrastructure and resources of one of the country's most loved and respected animal charities."
He added: "This partnership will help StreetVet continue to provide free, accessible veterinary care to those most in need, while further increasing the impact that Battersea has on the welfare of dogs and cats across the UK."
Photo: L-R Peter Laurie (Battersea), Jade Statt and Sam Joseph (StreetVet), Shaun Opperman (Battersea) and Blue the Staffie
Trilotab is licensed for the treatment of pituitary-dependent hypercortisolism (PDH) caused by an adrenocorticotrophic hormone (ACTH)-secreting pituitary adenoma, which accounts for 85% of spontaneous cases of Cushing’s, and for the treatment of adreno-dependent hyperadrenocorticism (ADH) caused by a cortisol-secreting adrenocortical tumour (ACT), which accounts for the remaining 15% of spontaneous cases1.
The new tablet is divisible into halves and quarters to facilitate dose adjustment and make administration easier.
Divided tablets remain stable outside of the blister packaging until the next dose is due, thereby avoiding wastage.
Trilotab tablets are chewable and chicken-flavoured to help improve treatment compliance.
They contain hydrolysed chicken flavouring so they can be prescribed for pets allergic to chicken.
Trilotab is administered once daily with food with a starting dose of 2mg trilostane/kg bodyweight.
The new tabs are available in three presentations: 10mg, 30mg, and 60mg presentations, which Virbac says should help practices reduce their dispensary stockholding.
Andrew Connolly, Marketing Director – UK & Ireland at Virbac, said: ‘The complex nature of Cushing’s syndrome in dogs can make it a challenging condition to manage for both the clinician and the pet owner.
"With the requirement for lifelong treatment, it is our hope that Trilotab’s easy administration and simplified dosing protocols will genuinely help to improve the lives of dogs affected by the disease, whilst making the clinician and pet owner’s lives just a little bit easier too!"
Dr Power faced a number of charges relating to alleged clinical and communications failings surrounding surgery carried out on two separate dogs on two separate occasions.
The first concerned laryngeal tieback surgery carried out on Harvey, a Tibetan Terrier in March 2018, and the second concerned oesophageal surgery carried out on a boxer dog, Boss, in October 2018.
The College withdrew a number of the charges at the start of the hearing, and more later after hearing from witnesses.
Of the remainder, Dr Power admitted that she had not undertaken pre-operative radiographs before proceeding with the laryngeal surgery, had failed to perform the surgery appropriately (she dissected excessive tissue and had inappropriately placed sutures), and had undertaken the surgery when it was outside her area of competence.
In relation to the oesophageal surgery, Dr Power admitted failing to provide a referral report and/or clinical records to the veterinary practice he was referred from, despite requests from the practice.
The Committee found that the majority of the charges which had not been withdrawn or admitted by Dr Power, not proven.
However, the Committee found that in addition to the admitted charges, Dr Power had subjected the dog undergoing oesophageal surgery to an excessive 9.5 hours of anaesthesia.
The Committee then went on to consider whether the proven charges amounted to serious professional conduct.
Counsel for the College submitted that Dr Power’s conduct breached the part of the Code of Professional Conduct relating to veterinary surgeons keeping within their area of competence and referring responsibly; and providing veterinary care that is appropriate and adequate.
In terms of aggravating factors, the College submitted that there was both actual injury to the animal, as well as actions that posed a risk of injury, that Dr Power financially benefitted from the alleged misconduct as she was paid to perform a procedure outside her competence, and that she occupied a position of increased trust and responsibility as she advertised herself as a practitioner who accepted referrals and was competent to perform soft tissue surgery.
Dr Power’s counsel submitted that the charges that had been found proven amounted to clinical and administrative failings and that this was not a case of a veterinary surgeon deliberately or recklessly acting outside of their capabilities, but rather a case where a diligent and responsible veterinary surgeon had fallen short in discrete areas of her clinical practice and had reasonably believed at the time that she was competent to perform the surgery.
The Committee found that although the conduct within the proven charges fell short of what would be reasonably expected of a veterinary surgeon, it did not fall so far short that her conduct constituted serious professional misconduct.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee understood that it had a responsibility to consider the wider public interest, taking into account the view of a reasonable member of the public in possession of all the relevant facts and information.
“The Committee considered that such a member of the public would understand that veterinary surgery is a challenging profession. It was of the view that such a member of the public would not expect perfection, but understand that any professional practitioner may make mistakes in the course of their practice.
“It is the judgement of this Committee that the respondent’s conduct does not constitute disgraceful conduct in a professional respect.”
The full findings of the Disciplinary Committee can be found at www.rcvs.org.uk/disciplinary
Titled 'Animal Welfare For The Many, Not The Few' (uh?), the policy proposes appointing an Animal Welfare Commissioner to ensure Government policy across Whitehall is informed by the latest scientific evidence on animal sentience.
The proposed policies in the document include a number of things the Conservatives have already been working on, such as:
Prohibiting the third party sale of puppies. All puppies will need to be sold with their mother on site.
Increasing maximum sentences for those convicted of animal cruelty.
Introducing mandatory CCTV in all slaughterhouses.
Enshrining the principle of animal sentience in law, covering all policy areas to prevent practices that expose animals to cruel and degrading treatment.
Introducing a ban on ivory trading.
However, Labour propose a number of additional ideas which are now open for a public consultation, including:
Improving accessibility to vets for those on low incomes/receiving financial support, working with organisations like the PDSA to explore how access to affordable vet care can be expanded.
Banning the use of animal shock collars, including sale and importation.
Expanding mandatory microchipping to cats.
Consulting with landlords and tenants on the ability for tenants to keep pets as default unless there is evidence that the animal is causing a nuisance.
Ending the badger cull.
Strengthening the Hunting Act, closing loopholes that allow for illegal hunting of foxes and hares.
Banning Foie Gras (which the Conservatives say is impossible under EU rules which Labour has said it wishes to continue following post-Brexit)
Mandatory labelling of domestic and imported meat, including country of origin, method of production and slaughter (stun or non-stun)
Requiring motorists to report accidents where an animal has been injured.
Banning wild animals in circuses.
Sue Hayman MP, Labour’s Shadow Environment Secretary, said: "Labour is the party of animal welfare. From bringing in the ban on fox hunting to tightening the rules on the transport of live animals, Labour has always been consistent in our leadership on matters of animal welfare.
"Today we’re making proposals for real, long-term progress. Our vision is one where no animal is made to suffer unnecessary pain and we continue to drive up standards and practice in line with the most recent advances and understanding."
Conservative MP Steve Double said: "Labour are belatedly playing catch-up with the huge progress made by this Government on animal welfare.
However, Labour wouldn’t even be able to deliver some of these promises because they want to keep following EU rules after Brexit.
From introducing mandatory CCTV into slaughter houses to increasing the maximum sentence for animal cruelty ten-fold, the Conservatives will continue taking the action needed to ensure animals receive the proper protection they deserve."
A free copy of the compendium has been sent to every veterinary practice in the UK, and it is also available online at: www.noahcompendium.co.uk. A special edition of the book commissioned by AMTRA will also be available for its SQPs shortly.
NOAH chief executive Dawn Howard said: "The NOAH Compendium, in all its formats, remains a major part of NOAH’s efforts to ensure appropriate access and responsible use of medicines for all animals. We are pleased it is even more comprehensive this year, as we continue to expand its list of contributors.
"Every NOAH member, as well as the non-member participants in the NOAH Compendium, is a signatory to the NOAH Code of Practice on Promotion, which demonstrates their commitment to operate above and beyond any regulatory requirements."
She added: “As well as product datasheets, the Compendium includes another vital resource – the contact details for each participating company. Company veterinary and technical advisors have detailed knowledge about their company’s medicines. The NOAH Code includes the requirement for NCAH qualification for NOAH staff in technical dialogue with prescribers and users of animal medicines – meaning their advice can be regarded as a valuable and trusted resource. They are ready to talk to prescribers about the use of a medicine in a particular animal or in a particular situation, as well as to explain any queries about the data sheet."
Veterinary practices that have not yet received a copy, perhaps because they are new or have changed address in the past year should contact NOAH (noah@noah.co.uk).
Extra copies are also available to order, for £47.50. Special prices are also available for bulk orders.
Currently Principal of the Royal Veterinary College, University of London, and previously Dean of the University of Glasgow’s School Of Veterinary Medicine, Stuart has been a member of RCVS Council since 2005, and served as RCVS President in 2014-15.
As chair of the Education Policy and Specialisation Committee in 2011, Stuart oversaw the College’s review of veterinary specialisation, which also led to the new Advanced Practitioner status.
He has also been a driving force behind the joint RCVS and BVA Vet Futures project since its inception in 2015.
As Chair of the RCVS Governance Panel, he recently saw through reform of the College’s governance arrangements to improve the efficiency and accountability of its decision-making processes.
Stuart has also chaired the RCVS Science Advisory Panel.
He continues to chair the College’s Mind Matters Initiative, which aims to improve the mental health and wellbeing of all those in the veterinary team.
A particularly notable achievement during his Presidential year was to allow UK veterinary surgeons to use the courtesy title ‘Doctor’ if they so wished.
Lizzie Lockett, RCVS Chief Executive said: "We have been incredibly fortunate to have someone of Stuart’s calibre, character and international renown on our Council for so many years. His contributions and commitment to the RCVS, as well as to the wider veterinary professions, are as significant as they are often understated.
"On behalf of RCVS Council and all the staff, I should like to say how delighted we are that he has been honoured in this way. Such recognition is very much deserved and we send him our warmest congratulations."